- Home
- ULH vs COLL Comparison
ULH vs COLL Comparison
Compare ULH & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- COLL
- Stock Information
- Founded
- ULH 1932
- COLL 2002
- Country
- ULH United States
- COLL United States
- Employees
- ULH N/A
- COLL N/A
- Industry
- ULH Trucking Freight/Courier Services
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- ULH Industrials
- COLL Health Care
- Exchange
- ULH Nasdaq
- COLL Nasdaq
- Market Cap
- ULH 1.2B
- COLL 1.0B
- IPO Year
- ULH 2005
- COLL 2015
- Fundamental
- Price
- ULH $43.15
- COLL $30.72
- Analyst Decision
- ULH Hold
- COLL Strong Buy
- Analyst Count
- ULH 1
- COLL 5
- Target Price
- ULH $44.00
- COLL $43.60
- AVG Volume (30 Days)
- ULH 43.9K
- COLL 441.9K
- Earning Date
- ULH 02-06-2025
- COLL 02-20-2025
- Dividend Yield
- ULH 0.97%
- COLL N/A
- EPS Growth
- ULH 24.75
- COLL 757.11
- EPS
- ULH 4.98
- COLL 2.16
- Revenue
- ULH $1,771,824,000.00
- COLL $599,245,000.00
- Revenue This Year
- ULH $9.86
- COLL $13.25
- Revenue Next Year
- ULH $0.66
- COLL $18.14
- P/E Ratio
- ULH $8.71
- COLL $14.24
- Revenue Growth
- ULH 2.42
- COLL 9.62
- 52 Week Low
- ULH $30.24
- COLL $28.39
- 52 Week High
- ULH $53.29
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- ULH 39.57
- COLL 45.90
- Support Level
- ULH $43.73
- COLL $32.28
- Resistance Level
- ULH $47.42
- COLL $33.45
- Average True Range (ATR)
- ULH 1.22
- COLL 1.07
- MACD
- ULH 0.10
- COLL -0.16
- Stochastic Oscillator
- ULH 16.04
- COLL 2.05
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.